![]() | |
Clinical data | |
---|---|
Trade names | Fexuclue |
Other names | Abeprazan; DWP14012; DWP-14012 |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H17F3N2O3S |
Molar mass | 410.41 g·mol−1 |
3D model ( JSmol) | |
| |
|
Fexuprazan (trade name Fexuclue) is a drug for the treatment of gastroesophageal reflux disease (GERD). [1] It is a potassium-competitive acid blocker. [2]
Fexuprazan is approved for use in South Korea and Mexico. [3] [4]